Cardiovascular Effects of Treadmill Training With Post-stroke Functional Electrical Stimulation
NCT ID: NCT05549141
Last Updated: 2022-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
28 participants
INTERVENTIONAL
2022-08-20
2023-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Treadmill Gait Training With Loading in Individuals With Stroke
NCT02113098
Enhanced Treadmill Gait Training With Lower Limb Support After Stroke
NCT03348215
Backward Treadmill Training in Patients With Chronic Stroke
NCT02710773
The Effectiveness of Body Weight Supported Treadmill Training in Stroke Patients
NCT04597658
Effects of Treadmill-Based Gait Training in Patients With Stroke
NCT07127861
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Type, location and study population: A longitudinal study of an experimental character, in which 26 adults and elderly with hemiparesis by stroke, of both sexes, who attended rehabilitation centers in Presidente Prudente/SP, participated. For the research, individuals were divided into Group A and Group B, randomized, matched by sex, age and according to the side of the body affected by the stroke.
Research design: Two treadmill gait training protocols were performed, which differ in the order of use of electrical stimulation in the groups. Each protocol will consist of two training phases, consisting of 6 sessions each, twice a week for 30 minutes. Subjects were assessed before starting the study (Initial Assessment), between phases (Intermediate Assessment) and at the end (Final Assessment).
To determine the speed/intensity to be programmed on the treadmill for the sessions, the value of the time required to perform the 10-meter test and the formula: speed equal to the ratio of meters divided by seconds were used, with 40% of this result being selected for speed programming. In order to establish a safety margin in training, risk stratification and training heart rate were used, making it possible to designate minimum and maximum limits.
Before and after training, participants rested (10 minutes) to collect cardiorespiratory parameters and HRV. During training, heart rate was monitored to prevent it from exceeding the maximum value, Modified Borg Scale (checks subjective sensation of effort) and HRV.
HRV analysis: For HRV analysis, 1000 consecutive RR intervals of the most stable segment of the tachogram will be performed. Only series with an error of less than 5% will be considered suitable for analysis. Data were filtered using Polar Precision Performance software (Polar Electro, Finland) in moderate mode, followed by a visual inspection.
HRV will be analyzed by linear methods (time and frequency domains and quantitative analysis of the Poincaré Plot) using the software Kubios® (v. 2.2, Kuopio, Finland). The non-linear HRV characteristics will be calculated through the Poincaré graph, Detrended Fluctuation Analysis (DFA), Recurrence Graph (RP) and Symbolic Analysis (SA).
The DFA exponents α1 and α2 will be considered using the software. The recurrence plot will be studied using Visual Recurrence Analysis software (v.4.9) and the configured parameters will be dimension = 10, delay = 1, radio = 70 and line = 2.
Data analysis: The data will be analyzed and if the assumptions of normality are not violated, the intergroup and intragroup data will be analyzed using analysis of variance (ANOVA) for repeated measures, Tukey's posthoc will be used and to identify differences, if any. In case of violation of normality assumptions, non-parametric tests such as Mann-Whitney and Kruskal-Wallis will be used. A significance level of p\<0.05 will be considered.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A 1
Treadmill gait training using an electrical stimulator, as first intervention.
treadmill gait training with gait facilitators
6 sessions of 30 minutes each of treadmill gait training with functional electrical stimulation as a gait facilitator
Group B1
Treadmill gait training without the use of an electrical stimulator, as second intervention.
treadmill gait training not-associated with gait facilitators
6 sessions of 30 minutes each of treadmill gait training
Group A2
Treadmill gait training without the use of an electrical stimulator, as first intervention.
treadmill gait training not-associated with gait facilitators
6 sessions of 30 minutes each of treadmill gait training
Group B2
Treadmill gait training using an electrical stimulator, as second intervention.
treadmill gait training with gait facilitators
6 sessions of 30 minutes each of treadmill gait training with functional electrical stimulation as a gait facilitator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
treadmill gait training with gait facilitators
6 sessions of 30 minutes each of treadmill gait training with functional electrical stimulation as a gait facilitator
treadmill gait training not-associated with gait facilitators
6 sessions of 30 minutes each of treadmill gait training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* authorization of individuals with the proper signature of the free and informed consent form.
Exclusion Criteria
* osteoarticular deformities
* cognitive impairment
* visual deficits
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of São Paulo
OTHER
Universidade do Oeste Paulista
OTHER
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Talita Dias da Silva
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Tereza Dantas
Role: STUDY_DIRECTOR
Universidade do Oeste Paulista
Talita da Silva
Role: PRINCIPAL_INVESTIGATOR
Federal University of São Paulo
Rodrigo Dias
Role: STUDY_CHAIR
Federal University of São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Comitê de Etica da Universidade do Oeste Paulista
Presidente Prudente, São Paulo, Brazil
Comitê de Etica da Universidade Federal de São Paulo
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Dunn A, Marsden DL, Nugent E, Van Vliet P, Spratt NJ, Attia J, Callister R. Protocol variations and six-minute walk test performance in stroke survivors: a systematic review with meta-analysis. Stroke Res Treat. 2015;2015:484813. doi: 10.1155/2015/484813. Epub 2015 Jan 20.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available.
Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1;93(5):1043-65. No abstract available.
Huikuri HV, Makikallio TH, Perkiomaki J. Measurement of heart rate variability by methods based on nonlinear dynamics. J Electrocardiol. 2003;36 Suppl:95-9. doi: 10.1016/j.jelectrocard.2003.09.021.
Related Links
Access external resources that provide additional context or updates about the study.
VISUAL RECURRENCE ANALYSIS.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
54747521.9.3001.5505
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.